Ausgabe 1/2021
Inhalt (30 Artikel)
Evaluation of online Spanish and English health materials for preventive mastectomy. are we providing adequate information?
Diana D. del Valle, Jaime A. Pardo, Amy M. Maselli, Monica G. Valero, Betty Fan, Nargiz Seyidova, Ted A. James, Bernard T. Lee
The impact of mandatory mammographic breast density notification on supplemental screening practice in the United States: a systematic review
Shuangqin Huang, Nehmat Houssami, Meagan Brennan, Brooke Nickel
The epithelial sodium channel has a role in breast cancer cell proliferation
Adam W. Ware, Joshua J. Harris, Tania L. Slatter, Heather E. Cunliffe, Fiona J. McDonald
Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial
Carina Strell, Axel Stenmark Tullberg, Reidunn Jetne Edelmann, Lars Andreas Akslen, Per Malmström, Mårten Fernö, Erik Holmberg, Arne Östman, Per Karlsson
DTX3 copy number increase in breast cancer: a study of associations to molecular subtype, proliferation and prognosis
Marit Valla, Signe Opdahl, Borgny Ytterhus, Anna Mary Bofin
Overexpression of Stat3 increases circulating cfDNA in breast cancer
Yi-Fei Wang, Xue-Jian Wang, Zhong Lu, Shu-Rong Liu, Yu Jiang, Xiao-Qing Wan, Cong-Cong Cheng, Li-Hong Shi, Li-Hua Wang, Yi Ding
Low RAI2 expression is a marker of poor prognosis in breast cancer
Sayaka Nishikawa, Yasuaki Uemoto, Tae-Sun Kim, Tomoka Hisada, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Yusuke Katagiri, Mitsuo Terada, Akiko Kato, Yu Dong, Hiroshi Sugiura, Katsuhiro Okuda, Hiroyuki Kato, Satoshi Osaga, Satoru Takahashi, Tatsuya Toyama
HER2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines
Lauren E. McLemore, Constance T. Albarracin, Stephen K. Gruschkus, Roland L. Bassett Jr, Yun Wu, Sagar Dhamne, Isaiah Yim, Kevin Lin, Isabelle Bedrosian, Nour Sneige, Hui Chen
Management of ipsilateral breast tumor recurrence following breast conservation surgery: a comparative study of re-conservation vs mastectomy
Astrid Botty Van den Bruele, Ishita Chen, Varadan Sevilimedu, Tiana Le, Monica Morrow, Lior Z. Braunstein, Hiram S. Cody III
A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application
David Richardson, Lin Zhan, Reshma Mahtani, Lynn McRoy, Debanjali Mitra, Maria Reynolds, Dawn Odom, Kelly Hollis, James A. Kaye, Cheryl Jones, Jeffrey Hargis
Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer
Satoshi Sueoka, Shinsuke Sasada, Norio Masumoto, Akiko Emi, Takayuki Kadoya, Morihito Okada
Long-term outcome of (neo)adjuvant zoledronic acid therapy in locally advanced breast cancer
Andrew P. Jallouk, Sriram Paravastu, Katherine Weilbaecher, Rebecca L. Aft
Performance of a novel protease-activated fluorescent imaging system for intraoperative detection of residual breast cancer during breast conserving surgery
Conor R. Lanahan, Bridget N. Kelly, Michele A. Gadd, Michelle C. Specht, Carson L. Brown, Kevin S. Hughes, Rong Tang, Upahvan Rai, Elena F. Brachtel, Travis Rice-Stitt, Barbara L. Smith
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer
Andrew Wardley, Javier Cortes, Louise Provencher, Kathy Miller, A. Jo Chien, Hope S. Rugo, Joyce Steinberg, Jennifer Sugg, Iulia C. Tudor, Manon Huizing, Robyn Young, Vandana Abramson, Ron Bose, Lowell Hart, Stephen Chan, David Cameron, Gail S. Wright, Marie-Pascale Graas, Patrick Neven, Andrea Rocca, Stefania Russo, Ian E. Krop
Impact of sequence order of anthracyclines and taxanes in neoadjuvant chemotherapy on pathologic complete response rate in HER2-negative breast cancer patients
M. E. Tesch, S. K. Chia, C. E. Simmons, N. LeVasseur
Trends in neoadjuvant chemotherapy versus surgery-first in stage I HER2-positive breast cancer patients in the National Cancer DataBase (NCDB)
Michael Zeidman, Hank Schmidt, J. Jaime Alberty-Oller, Kereeti V. Pisapati, Soojin Ahn, Madhu Mazumdar, Meng Ru, Erin Moshier, Elisa Port
Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?
Danalyn Byng, Valesca P. Retèl, Michael Schaapveld, Jelle Wesseling, Wim H. van Harten
Overcoming disparities: Multidisciplinary breast cancer care at a public safety net hospital
Kristin N. Kelly, Alexandra Hernandez, Sina Yadegarynia, Emily Ryon, Dido Franceschi, Eli Avisar, Erin N. Kobetz, Nipun Merchant, Susan Kesmodel, Neha Goel
Identification of factors that influence the decision to take chemoprevention in patients with a significant family history of breast cancer: results from a patient questionnaire survey
Stacey Jones, Brian Hogan, Kirtida Patel, Shiwei Ooi, Philip Turton, Rajgopal Achuthan, Baek Kim
Association of mammographic density measures and breast cancer “intrinsic” molecular subtypes
Geffen Kleinstern, Christopher G. Scott, Rulla M. Tamimi, Matthew R. Jensen, V. Shane Pankratz, Kimberly A. Bertrand, Aaron D. Norman, Daniel W. Visscher, Fergus J. Couch, Kathleen Brandt, John Shepherd, Fang-Fang Wu, Yunn-Yi Chen, Steven R. Cummings, Stacey Winham, Karla Kerlikowske, Celine M. Vachon
Factors associated with waiting time to breast cancer diagnosis among symptomatic breast cancer patients: a population-based study from Ontario, Canada
Colleen Webber, Marlo Whitehead, Andrea Eisen, Claire M. B. Holloway, Patti A. Groome
The prognostic significance of metastatic pattern in stage IV male breast cancer at initial diagnosis: a population-based study
José Pablo Leone, Bernardo Amadeo Leone, Ariel O. Zwenger, Carlos Teodoro Vallejo, Alberto Omar Romero, Mario Raúl Machiavelli, Juan Eduardo Pérez, Julieta Leone
Patterns of treatment and outcome of ductal carcinoma in situ in the Netherlands
Jacky D. Luiten, Ernest J. T. Luiten, Maurice J. C. van der Sangen, Willem Vreuls, Lucien E. M. Duijm, Vivianne C. G. Tjan-Heijnen, Adri C. Voogd
Association between radiologists’ and facilities’ characteristics and mammography screening detection of ductal carcinoma in situ
Isabelle Théberge, Nathalie Vandal, Linda Perron, Marie-Hélène Guertin
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
Johanna Alanko, Minna Tanner, Ritva Vanninen, Anssi Auvinen, Jorma Isola
Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis
AnnaLynn M. Williams, Carly Paterson Khan, Charles E. Heckler, Debra L. Barton, Mary Ontko, Jodi Geer, Amber S. Kleckner, Shaker Dakhil, Jerry Mitchell, Karen M. Mustian, Luke J. Peppone, Victor Kipnis, Charles S. Kamen, Ann M. O’Mara, Michelle C. Janelsins
Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer
Mei Wei, Xuechen Wang, Danielle N. Zimmerman, Lindsay M. Burt, Benjamin Haaland, N. Lynn Henry
Call to action: breast cancer screening recommendations for Black women
Bridget A. Oppong, Samilia Obeng-Gyasi, Theresa Relation, Lucile Adams-Campbell
Influence of different response after neoadjuvant chemotherapy on time of surgery in breast cancer patients
Darko Zdravkovic, Simona Petricevic, Borislav Toskovic
Correction to: Mammography use and breast cancer incidence among older U.S. women
Sara D. Turbow, Mary C. White, Erica S. Breslau, Susan A. Sabatino